International Stem Cell (ISCO) Prepaid Assets (2010 - 2026)
International Stem Cell's (ISCO) quarterly Prepaid Assets came in at $187000.0 in Q2 2026, down 30.48% year-over-year from $269000.0 in Q2 2025, and up 3.31% quarter-over-quarter from $181000.0 in Q4 2025.
Analysis
International Stem Cell (ISCO) Prepaid Assets (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Prepaid Assets for 17 consecutive years, with $187000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets fell 30.48% year-over-year to $187000.0 in Q2 2026; TTM through Jun 2026 was $187000.0, a 30.48% decrease from a year earlier, with the FY2025 full-year figure at $181000.0, up 47.15% from the prior year.
- Prepaid Assets was $187000.0 for Q2 2026 at International Stem Cell, up from $181000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $384000.0 in Q2 2022 and troughed at $90000.0 in Q4 2022.
- A 5-year average of $232117.6 and a median of $267000.0 in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 55.43% in 2024 and surged 47.15% in 2025, its largest moves.
- Over 5 years, Prepaid Assets stood at $90000.0 in 2022, then rose by 6.67% to $96000.0 in 2023, then climbed by 28.12% to $123000.0 in 2024, then jumped by 47.15% to $181000.0 in 2025, then climbed by 3.31% to $187000.0 in 2026.
- The last three Prepaid Assets figures came in at $187000.0 (Q2 2026), $181000.0 (Q4 2025), and $162000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | International Stem Cell | 2.84 Mn | 1.75 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 187,000.00 |
| Dec 31, 2025 | 181,000.00 |
| Sep 30, 2025 | 162,000.00 |
| Jun 30, 2025 | 269,000.00 |
| Mar 31, 2025 | 277,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 119,000.00 |
| Jun 30, 2024 | 304,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 267,000.00 |
| Jun 30, 2023 | 344,000.00 |
| Mar 31, 2023 | 311,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Jun 30, 2022 | 384,000.00 |
| Mar 31, 2022 | 338,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 174,000.00 |
| Jun 30, 2021 | 416,000.00 |